back to top
HomeMarketReactions to China's anti-subsidy probe on EU dairy imports By Reuters

Reactions to China's anti-subsidy probe on EU dairy imports By Reuters

-

BEIJING (Reuters) – China launched an anti-subsidy investigation into dairy imports from the European Union a day after the bloc’s revised tariff plan for electrical autos made within the Asian big.

Wednesday’s inquiry concentrating on cheese, milks and lotions meant for human consumption, got here after the EU amended proposed punitive duties on Chinese language EV imports to 36.3% from an preliminary 37.6%. Beijing had urged Brussels to desert the tariffs.

EUROPEAN UNION CHAMBER OF COMMERCE IN CHINA:

“Regrettably, using commerce defence devices by one authorities is more and more being responded to seemingly in form by the recipient authorities.

“Therefore, in view of the European Commission disclosing the definitive findings of its probe into BEVs from China, China’s decision to launch an anti-subsidy probe should not be considered a surprise.

“The Chamber will probably be monitoring the investigation and hopes will probably be performed pretty and transparently. We count on our affected member firms to co-operate to the fullest with the investigation.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here

CAPTCHA


LATEST POSTS

If the inventory market crashes, I'll purchase this surging FTSE 100 inventory instantly 

Picture supply: Getty Pictures Traditionally, there have been important inventory market crashes in September...

Will Bitcoin’s realized value drop to $31K? Ranges to watch

BTC has dropped beneath its 200-day shifting common for the second time, the primary being July 2024. An analyst predicted a drop to BTC’s realized value...

eToro buying and selling: U.S. shoppers restricted to BTC, ETH, BCH put up SEC deal

eToro buying and selling platform will limit U.S. crypto trades to Bitcoin, Ethereum, and Bitcoin Money following a settlement with the SEC. The SEC has fined...

Celularity pronounces government departure By Investing.com

Celularity Inc. (NASDAQ:CELU), a biotechnology firm specializing in pharmaceutical preparations, introduced the resignation of its Chief Medical Officer, Adrian Kilcoyne, M.D., M.P.H., M.B.A. Dr. Kilcoyne...

Most Popular